Goldman Sachs Group, Inc. (The) Reiterates Buy Rating for Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “buy” rating reaffirmed by equities researchers at Goldman Sachs Group, Inc. (The) in a research report issued on Saturday.

ISRG has been the topic of a number of other research reports. Vetr upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.37 target price on the stock in a report on Thursday, August 17th. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 target price on the stock in a report on Tuesday, November 14th. Morgan Stanley restated an “overweight” rating and set a $118.89 target price (up previously from $105.56) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Finally, Canaccord Genuity restated a “hold” rating and set a $111.11 target price (up previously from $96.67) on shares of Intuitive Surgical in a report on Wednesday, July 26th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $155.78.

Shares of Intuitive Surgical (ISRG) opened at $392.48 on Friday. The firm has a market cap of $43,976.60, a price-to-earnings ratio of 51.94, a P/E/G ratio of 5.45 and a beta of 0.47. Intuitive Surgical has a fifty-two week low of $203.57 and a fifty-two week high of $400.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, beating the Zacks’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The firm had revenue of $806.10 million for the quarter, compared to analysts’ expectations of $753.25 million. During the same quarter in the previous year, the business posted $2.06 EPS. The company’s quarterly revenue was up 18.0% on a year-over-year basis. equities analysts expect that Intuitive Surgical will post 7.85 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Goldman Sachs Group, Inc. (The) Reiterates Buy Rating for Intuitive Surgical, Inc. (ISRG)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://sportsperspectives.com/2017/11/19/goldman-sachs-group-inc-the-reiterates-buy-rating-for-intuitive-surgical-inc-isrg.html.

In other Intuitive Surgical news, VP Jamie Samath sold 1,564 shares of the business’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.19, for a total value of $580,541.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Craig H. Barratt sold 15,000 shares of the business’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total value of $5,567,700.00. Following the completion of the transaction, the insider now directly owns 7,500 shares of the company’s stock, valued at approximately $2,783,850. The disclosure for this sale can be found here. In the last three months, insiders sold 36,656 shares of company stock valued at $15,432,702. 2.20% of the stock is owned by insiders.

A number of large investors have recently modified their holdings of the business. ETF Managers Group LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $110,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $120,000. Parallel Advisors LLC grew its stake in shares of Intuitive Surgical by 3.9% during the 2nd quarter. Parallel Advisors LLC now owns 159 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 6 shares during the period. Lincoln National Corp bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $200,000. Finally, MUFG Americas Holdings Corp bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $208,000. 31.30% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply